首页> 外文期刊>Mayo Clinic Proceedings >Blurred boundaries: The therapeutics and politics of medical marijuana
【24h】

Blurred boundaries: The therapeutics and politics of medical marijuana

机译:界限模糊:医用大麻的疗法和政治

获取原文
获取原文并翻译 | 示例
       

摘要

For 5 millennia, Cannabis sativa has been used throughout the world medically, recreationally, and spiritually. From the mid-19th century to the 1930s, American physicians prescribed it for a plethora of indications, until the federal government started imposing restrictions on its use, culminating in 1970 with the US Congress classifying it as a Schedule I substance, illegal, and without medical value. Simultaneous with this prohibition, marijuana became the United States' most widely used illicit recreational drug, a substance generally regarded as pleasurable and relaxing without the addictive dangers of opioids or stimulants. Meanwhile, cannabis never lost its cachet in alternative medicine circles, going mainstream in 1995 when California became the first of 16 states to date to legalize its medical use, despite the federal ban. Little about cannabis is straightforward. Its main active ingredient, δ-9-tetrahydrocannabinol, was not isolated until 1964, and not until the 1990s were the far-reaching modulatory activities of the endocannabinoid system in the human body appreciated. This system's elucidation raises the possibility of many promising pharmaceutical applications, even as draconian federal restrictions that hamstring research show no signs of softening. Recreational use continues unabated, despite growing evidence of marijuana's addictive potential, particularly in the young, and its propensity for inducing and exacerbating psychotic illness in the susceptible. Public approval drives medical marijuana legalization efforts without the scientific data normally required to justify a new medication's introduction. This article explores each of these controversies, with the intent of educating physicians to decide for themselves whether marijuana is panacea, scourge, or both. PubMed searches were conducted using the following keywords: medical marijuana, medical cannabis, endocannabinoid system, CB1 receptors, CB2 receptors, THC, cannabidiol, nabilone, dronabinol, nabiximols, rimonabant, marijuana legislation, marijuana abuse, marijuana dependence, and marijuana and schizophrenia. Bibliographies were hand searched for additional references relevant to clarifying the relationships between medical and recreational marijuana use and abuse.
机译:五千年来,大麻在医学,娱乐和精神上已在世界范围内使用。从19世纪中叶到1930年代,美国医生将其用于多种适应症,直到联邦政府开始对其进行限制,直到1970年美国国会将其归类为附表I物质,非法和无医疗价值。与此禁令同时,大麻成为美国使用最广泛的非法休闲药物,这种药物通常被认为是令人愉悦和放松的物质,没有阿片类药物或兴奋剂的致瘾性危险。同时,大麻从未在替代医学界失去名声,1995年成为主流,当时加利福尼亚州成为迄今为止16个州中第一个使医学使用合法化的州,尽管有联邦禁令。几乎没有大麻很简单。它的主要活性成分δ-9-四氢大麻酚直到1964年才被分离出来,直到1990年代人们才认识到内源性大麻素系统在人体中具有深远的调节作用。该系统的阐明增加了许多有前途的药物应用的可能性,即使在严厉的联邦限制下,ham绳肌研究没有丝毫减弱的迹象。尽管有越来越多的证据表明,大麻的成瘾潜力(尤其是在年轻人中)以及其在易感人群中诱发和加剧精神病的倾向,但娱乐活动的使用仍在继续。公众的认可推动了医用大麻合法化工作的开展,而没有通常的科学数据来证明新药的引入是正确的。本文探讨了所有这些争议,目的是教育医生自己确定大麻是灵丹妙药,祸害还是两者兼而有之。 PubMed搜索使用以下关键字进行:医用大麻,医用大麻,内源性大麻素系统,CB1受体,CB2受体,THC,大麻酚,萘比隆,屈大麻酚,纳比昔莫尔,利莫那班特,大麻法规,大麻滥用,大麻依赖以及大麻和模式。手工检索了参考书目,以查找与澄清医用和休闲用大麻与滥用之间的关系有关的其他参考资料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号